MAIT Cells Confer Resistance to Lenvatinib Plus Anti-Pd1 Antibodies in Hepatocellular Carcinoma Through TNF-TNFRSF1B Pathway.
Clinical Immunology（2023）
Key words
Hepatocellular carcinoma,Lenvatinib,Anti-PD1 antibodies,Tumor microenvironment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined